The AI Industry Series: Top Healthcare AI Trends To Watch
CB Insights
SEPTEMBER 10, 2018
Big pharma’s AI re-branding . The FDA is focused on clearly defining and regulating “software-as-a-medical-device,” especially in the light of recent rapid advances in AI. Big pharma’s AI re-branding. But accessibility to Facebook and a lack of regulations makes verification of some bots and their privacy terms difficult.
28 
Let's personalize your content